Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02130960 · ClinicalTrials.gov registry record
Resting Metabolic Rate Reliability
A clinical trial, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- 30
- Enrollment target
NCT02130960: Completed study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT02130960 is a clinical trial that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02130960 has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This research is being conducted to study the reliability of a method used to measure resting metabolic rate, or how much energy a person expends while at rest.
Primary Outcome
The within-subject coefficient of variation for resting metabolic rate (RMR) will be less than 10%. Testing will occur on non-consecutive days, with a compliance and menstrual cycle questionnaire prior to testing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-12 |
What the finished NCT02130960 record still lists
NCT02130960 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02130960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02130960 about?
NCT02130960 is a clinical study titled "Resting Metabolic Rate Reliability". This research is being conducted to study the reliability of a method used to measure resting metabolic rate, or how much energy a person expends while at rest.
What is the current status of trial NCT02130960?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2014-04. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02130960?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia